header logo
Vallibel FD
vallible LE
Latest
Moderna vaccine appears to work against new Covid-19 variants
Moderna vaccine appears to work against new Covid-19 variants
Mobitel inner 1278

Moderna’s Covid-19 vaccine appears to work against new, more infectious variants of the pandemic virus found in the UK and South Africa, say scientists from the US pharmaceutical company.

 

Early laboratory tests suggest antibodies triggered by the vaccine can recognise and fight the new variants.

 

More studies are needed to confirm this is true for people who have been vaccinated.

 

The new variants have been spreading fast in a number of nations.

 

They have undergone changes or mutations that mean they can infect human cells more easily than the original version of coronavirus that started the pandemic.

 

Experts think the UK strain, which emerged in September, may be up to 70% more transmissible.

 

Current vaccines were designed around earlier variants, but scientists believe they should still work against the new ones, although perhaps not quite as well. There are already some early results that suggest the Pfizer vaccine protects against the new UK variant.

 

For the Moderna study, researchers looked at blood samples taken from eight people who had received the recommended two doses of the Moderna vaccine.

 

The findings are yet to be peer reviewed, but suggest immunity from the vaccine recognises the new variants.

 

Neutralising antibodies, made by the body’s immune system, stop the virus from entering cells.

 

Blood samples exposed to the new variants appeared to have sufficient antibodies to achieve this neutralising effect, although it was not as strong for the South Africa variant as for the UK one.

 

Moderna says this could mean that protection against the South Africa variant might disappear more quickly.

 

Prof Lawrence Young, a virus expert at Warwick Medical School in the UK, said this would be concerning.

 

Moderna is currently testing whether giving a third booster shot might be beneficial.

 

Like other scientists, the company is also investigating whether redesigning the vaccine to be a better match for the new variants will be beneficial.

 

Stephane Bancel, chief executive officer of Moderna, said the company believed it was “imperative to be proactive as the virus evolves”.

 

UK regulators have already approved Moderna’s vaccine for rollout on the NHS, but the 17m pre-ordered doses are not expected to arrive until Spring.

 

The vaccine works in a similar way to the Pfizer one already being used in the UK.

 

More than 6.3 million people in the UK have already received a first dose of either the Pfizer or the AstraZeneca vaccine.

 

Source: BBC
-AgenciesModerna’s Covid-19 vaccine appears to work against new, more infectious variants of the pandemic virus found in the UK and South Africa, say scientists from the US pharmaceutical company.

 

Early laboratory tests suggest antibodies triggered by the vaccine can recognise and fight the new variants.

 

More studies are needed to confirm this is true for people who have been vaccinated.

 

The new variants have been spreading fast in a number of nations.

 

They have undergone changes or mutations that mean they can infect human cells more easily than the original version of coronavirus that started the pandemic.

 

Experts think the UK strain, which emerged in September, may be up to 70% more transmissible.

 

Current vaccines were designed around earlier variants, but scientists believe they should still work against the new ones, although perhaps not quite as well. There are already some early results that suggest the Pfizer vaccine protects against the new UK variant.

 

For the Moderna study, researchers looked at blood samples taken from eight people who had received the recommended two doses of the Moderna vaccine.

 

The findings are yet to be peer reviewed, but suggest immunity from the vaccine recognises the new variants.

 

Neutralising antibodies, made by the body’s immune system, stop the virus from entering cells.

 

Blood samples exposed to the new variants appeared to have sufficient antibodies to achieve this neutralising effect, although it was not as strong for the South Africa variant as for the UK one.

 

Moderna says this could mean that protection against the South Africa variant might disappear more quickly.

 

Prof Lawrence Young, a virus expert at Warwick Medical School in the UK, said this would be concerning.

 

Moderna is currently testing whether giving a third booster shot might be beneficial.

 

Like other scientists, the company is also investigating whether redesigning the vaccine to be a better match for the new variants will be beneficial.

 

Stephane Bancel, chief executive officer of Moderna, said the company believed it was “imperative to be proactive as the virus evolves”.

 

UK regulators have already approved Moderna’s vaccine for rollout on the NHS, but the 17m pre-ordered doses are not expected to arrive until Spring.

 

The vaccine works in a similar way to the Pfizer one already being used in the UK.

 

More than 6.3 million people in the UK have already received a first dose of either the Pfizer or the AstraZeneca vaccine.

 

Source: BBC
-Agencies

 

 

 

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them (mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Comments

0
Comments are disabled

Note: Due to legal constraints, the Ada Derana Editorial team has taken a decision to disable comments on all articles concerning ongoing court procedures.

MostRead
Mobitel 1278
VideoStories
Rajangane Saddharathana remanded over violent clashes in A’pura,  three other suspects granted bail

Rajangane Saddharathana remanded over violent clashes in A’pura, three other suspects granted bail

Appeals Court upholds four-year prison sentence  imposed on Ven. Gnanasara Thero

Appeals Court upholds four-year prison sentence imposed on Ven. Gnanasara Thero

Court suspends bail granted to Namal Rajapaksa Shashi Weerawansa’s two-year prison sentence upheld

Court suspends bail granted to Namal Rajapaksa Shashi Weerawansa’s two-year prison sentence upheld

 “I exposed corruption and not wronged” Trade union activist Ananda Palitha remanded until Nov. 25

“I exposed corruption and not wronged” Trade union activist Ananda Palitha remanded until Nov. 25

Trade union actions continue against 2027 Budget; Monday, declared a national day of protest

Trade union actions continue against 2027 Budget; Monday, declared a national day of protest

 Anuradhapura Sacred City Development Plan; Acting Atamasthanadhipathi calls for public cooperation

Anuradhapura Sacred City Development Plan; Acting Atamasthanadhipathi calls for public cooperation

 Namal produced in court over ‘Krrish’ transaction case; CID findings to court in Jan. 2027

Namal produced in court over ‘Krrish’ transaction case; CID findings to court in Jan. 2027

CAA issues notice to LAUGFS Gas;Supply gas or refund customers who purchased cylinders, company told

CAA issues notice to LAUGFS Gas;Supply gas or refund customers who purchased cylinders, company told

Sajith calls for stronger Sri Lanka-China ties;  Focus on innovation and sustainable economic growth

Sajith calls for stronger Sri Lanka-China ties; Focus on innovation and sustainable economic growth

"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

Another bankruptcy risk?  Opposition questions feasibility of Rs. 2 trillion capital spending target

Another bankruptcy risk? Opposition questions feasibility of Rs. 2 trillion capital spending target

Global Lankan Entrepreneur Club launched;  Dilith Jayaweera unveils global business platform

Global Lankan Entrepreneur Club launched; Dilith Jayaweera unveils global business platform

Heavy rains expected in Northern and Eastern areas  - Met Department warns

Heavy rains expected in Northern and Eastern areas - Met Department warns

Van driver arrested after collision with motorcycle  kills father and son in Chavakachcheri

Van driver arrested after collision with motorcycle kills father and son in Chavakachcheri

Lassana Flora